IBM and Siemens Healthineers has entered into a five year, global strategic alliance in Population Health Management (PHM).
The alliance aims to help hospitals, health systems, integrated delivery networks, and other providers deliver value-based care to patients with complex, chronic and costly conditions such as heart disease and cancer.
The health-focused alliance is the first of its kind for the companies, which have a longstanding global relationship that spans diverse industry sectors including IBMs work with Siemens Building Technologies, Siemens PLM and Siemens Digital Grid. It also marks Siemens entry into PHM.
Siemens Healthineers and IBM Watson Health intend to help healthcare professionals navigate unprecedented changes propelled by a growing volume and diversity of health data, an aging global population, increasing prevalence of chronic diseases, changes in healthcare payment models, and the digitization and consumerization of healthcare.
The alliance leverages the expertise and global reach of both companies, including Siemens track record introducing technology-driven innovations to a broad range of providers and IBM’s unique cognitive healthcare offerings. As part of the alliance, Siemens Healthineers will offer PHM solutions and services from IBM Watson Health. These offerings are designed to help meet hospital and healthcare systems’ demands for value-based care analytics and reporting, and patient engagement.
Siemens Healthineers will also provide consulting services to support providers in their transition to value-based care.
“Combining our strengths, Siemens Healthineers and IBM can effectively help providers transition to a value-based healthcare environment,” said Matthias Platsch, head of Services at Siemens Healthineers. “We will bring the power of Siemens Healthineers’ extensive relationships with providers and our deep domain expertise in clinical workflows, services, and digital health technologies to bear to help bring population health management offerings to healthcare providers. The new alliance fits perfectly into the services business of Siemens Healthineers. Thus we will enter the rapidly growing PHM market which is expected to play a significant role in end-to-end value-based healthcare.”
Under the strategic alliance, it is the intent of IBM and Siemens to work together to jointly develop and deploy new PHM offerings leveraging each company’s expertise and assets, including those added to the Watson Health portfolio from acquisitions such as Phytel and Explorys.
“We are at an unprecedented time in healthcare. Mature and developing markets are increasingly focused on how patient outcomes are optimized, quality is standardized among individuals and across populations, and costs are reduced,” said Deborah DiSanzo, general manager for IBM Watson Health. “Siemens and IBM are ideal partners to work at the forefront of this evolution and enable personalized healthcare in the U.S. and globally.”